Importantly, in 2012 it was found that 4–10% of CRC patients harbor gene fusions of the RSPO2 and RSPO3 genes with EIF3E and PTPRK respectively, co-occurring with enhanced expression of the considerate RSPO gene [49, 50]. Here, RSPO3 is linked to colorectal carcinoma.